This Article Full Text Full Text (PDF) Other Versions of this Article: CVI.00439-07v1 15/3/513    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Google Scholar Articles by Iwashita, H. Articles by Akaike, T. PubMed PubMed Citation Articles by Iwashita, H. Articles by Akaike, T.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, March 2008, p. 513-521, Vol. 15, No. 3
1071-412X/08/$08.00+0     doi:10.1128/CVI.00439-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Identification of the Major Antigenic Protein of Helicobacter cinaedi and Its Immunogenicity in Humans with H. cinaedi Infections

Department of Microbiology,¹ Department of Gastroenterology and Hepatology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan,² Department of Microbiology, School of Pharmacy, Aichi Gakuin University, Nagoya 464-8650, Japan,³ Chemo-Sero-Therapeutic Research Institute, Kumamoto 860-8568, Japan,⁴ Department of Infectious Diseases, Faculty of Medicine, Oita University, Oita 879-5593, Japan,⁵ Kumamoto Orthopedic Hospital, Kumamoto 862-0976, Japan⁶

Received 1 November 2007/ Returned for modification 29 November 2007/ Accepted 17 December 2007

Helicobacter cinaedi infection is now recognized as an increasingly important emerging disease. Its pathogenesis and epidemiological features are not fully understood, however. Here, we investigated the antigenic protein of H. cinaedi and the immunological response to it in H. cinaedi-infected patients. We constructed a genomic library of H. cinaedi from an H. cinaedi clinical isolate, and various H. cinaedi recombinant proteins were expressed. We identified the 30-kDa protein, encoded in an 822-bp H. cinaedi genome, as a major antigen, which was specifically recognized by serum from an H. cinaedi-immunized rabbit and H. cinaedi-infected patients. The gene encoding this 30-kDa antigen had high sequence similarity with genes encoding putative membrane proteins of bacteria. To evaluate whether the 30-kDa protein can be applied in serological testing for H. cinaedi infections, the recombinant protein was expressed in Escherichia coli as a His-tagged fusion protein and purified by Ni²⁺ affinity chromatography. Western blot analysis revealed strong immunoreactivity of the 31-kDa fusion protein with serum antibody from patients infected with H. cinaedi, but such an immunoreaction was absent or was very weak with uninfected control serum. An enzyme-linked immunosorbent assay using this H. cinaedi major antigen showed significantly high antibody titers for H. cinaedi-infected subjects compared with those of various control groups. We therefore conclude that the 30-kDa putative membrane protein is a major antigen of H. cinaedi and is useful for immunological and serological testing for clinical diagnosis and for further epidemiological study of H. cinaedi infection in humans.

Published ahead of print on 2 January 2008.